Breast cancer follow-up: one-size-fits-all or tailored to you?
NCT ID NCT05365230
First seen Nov 25, 2025 · Last updated May 24, 2026 · Updated 22 times
Summary
This study looked at whether a personalized follow-up schedule is better than standard guidelines for women who finished treatment for early-stage breast cancer. 261 participants were randomly assigned to either a tailored plan or the usual every-3-to-6-month visits. The goal was to see which approach improves quality of life and reduces fear of the cancer coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, K1H8M2, Canada
Conditions
Explore the condition pages connected to this study.